A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT01564784 · COMPLETED
Trial details
- NCT number
- NCT01564784
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-02
- Primary completion
- 2016-03-08
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.